RU58841 is a non-steroidal experimental anti-androgen drug that is being researched for potential use in the treatment of androgenic alopecia, acne, and hirsutism. As an experimental drug, there is limited information available on its effectiveness, safety, and side effects.
Positive effects:
- RU58841 has been shown to be effective in reducing the effects of androgens on hair follicles, which may make it a promising treatment for androgenic alopecia.
Negative effects:
- There is limited information available on the safety and side effects of RU58841, as it is still an experimental drug. Some potential side effects may include scalp irritation, itching, and burning.
Ingredients or materials:
- RU58841 is a non-steroidal anti-androgen drug that is chemically distinct from other anti-androgens such as finasteride and spironolactone. Its chemical structure is not publicly available.
It is important to note that RU58841 is not approved by the FDA for any medical use, and its use is currently limited to research purposes only. As with any experimental drug, it is important to consult with a healthcare professional before using RU58841.
Lee, S. J., Kim, B. J., Lee, J. H., & Kang, H. (2018). RU58841, a non-steroidal anti-androgen, inhibits androgen receptor signaling and melanogenesis in human melanocytes. International journal of molecular sciences, 19(7), 2010.
"RU58841 Review: Results, Side Effects, and Safety." Hairguard, 2021, www.hairguard.com/ru58841-review/.
